Diabordo, Judelyn D.
HRN: 05-08-04 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2025
CEFUROXIME 1.5GM (VIAL)
10/28/2025
10/29/2025
IVTT
1.5g
Q8h
UTI
Checking Final Appropriateness